Loading...
Smoking prolongs the infectivity of patients with tuberculosis.
Siddiqui, U A ; O'Toole, M ; Kabir, Z ; Qureshi, S ; Gibbons, N ; Kane, M ; Keane, J
Siddiqui, U A
O'Toole, M
Kabir, Z
Qureshi, S
Gibbons, N
Kane, M
Keane, J
Advisors
Editors
Other Contributors
Date
2010-10
Date Submitted
Keywords
Other Subjects
Subject Mesh
Adult
Antitubercular Agents
Cross-Sectional Studies
Female
Humans
Male
Retrospective Studies
Smoking
Sputum
Tuberculosis, Pulmonary
Antitubercular Agents
Cross-Sectional Studies
Female
Humans
Male
Retrospective Studies
Smoking
Sputum
Tuberculosis, Pulmonary
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Loading...
Article5761.pdf
Adobe PDF, 10.25 KB
Alternative Titles
Publisher
Abstract
We sought to establish if smokers on anti-tuberculosis treatment are more likely to have a prolonged period of infectivity, compared to non-smoking tuberculosis patients, in a low tuberculosis prevalence country. We conducted a cross-sectional, retrospective study in Ireland that recruited 53 microbiologically confirmed cases of pulmonary tuberculosis (PTB). The age-sex adjusted odds ratios (AOR) suggest that the infectivity status of PTB on treatment was four times more likely to be prolonged beyond 6-8 weeks, if the cases had a smoking history (AOR: 4.42; 95% CI: 1.23; 15.9). Smoking was associated with delayed sputum smear conversion in PTB patients on treatment.
Language
en
ISSN
0332-3102
eISSN
ISBN
DOI
PMID
21186753
